Citations

Clear

4847 citation(s) found for "Tu, Eric".

A Systematic Review of Post-Procedural Rehabilitation Protocols following Percutaneous Needle Tenotomy and Ultrasonic Debridement for Gluteal, Proximal Hamstring, and Patellar Tendinopathy
Buttinger, Jessica N., Johnson, A, Twohey, Eric E. , Gibson, Dylan J. , Nagelli, Christopher V. , Johnson, Shelby E. , Romero, Joshua M., Johnson, Andrew J, Twohey, Eric , Romero, Joshua , Johnson, Andrew

Mayo Clinic

American Journal of Physical Medicine & Rehabilitation | June 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/phm.0000000000003031 | PMID 42299894 Get It

Objective: Percutaneous needle tenotomy (PNT) and ultrasonic debridement (UD) are minimally invasive interventions for the management of chronic tendinopathy. Despite their increasing use, no standardized, evidence-based rehabilitation guidelines currently exist to direct clinicians in post-procedural management. This systematic review aimed to characterize and synthesize reported rehabilitation protocols following PNT and UD for patellar, proximal hamstring, and gluteal tendinopathies. Design: Systematic Review Results: Twenty-seven studies met inclusion criteria, with patellar tendon procedures (n=13) being the most common, followed by gluteal (n=6), proximal hamstring (n=3), and multi-tendon protocols (n=5). Of the included studies, 21 (78%) utilized percutaneous needle tenotomy (PNT) and six (22%) used ultrasound debridement or Tenex. Exercise restrictions were mandated in 19 studies (70%), while 12 (44%) provided a detailed, structured rehabilitation program, frequently emphasizing eccentric loading for patellar and hamstring tendons. Weight-bearing limitations were uncommon, appearing in only three studies (11%). Fifteen studies (56%) combined the procedure with platelet-rich plasma (PRP). Pharmacological protocols also showed high variance, with NSAID restrictions ranging from 1 to 28 days and corticosteroid avoidance lasting between 10 days and one year. Overall, substantial variability remains regarding recommended activity progression, exercise initiation, and mechanical loading strategies across current research. Conclusion: PNT and UD appear effective for managing refractory tendinopathy, yet post-procedure rehabilitation guidelines remain inconsistent and supported by limited high-quality evidence. Future research should aim to identify key variables that guide individualized rehabilitation progressions, optimizing recovery timelines, and facilitating safe and efficient return to activity following PNT and UD procedures.
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)
Andrieu, Sandrine, Bradshaw, Angela, Carmona, Ralph C., Iwatsubo, Takeshi, Hansson, Oskar, Jr, Clifford R Jack, Jicha, Gregory A, McDade, DO Eric, Mummery, Catherine J, Petersen, Ronald C, Robinson, Shelagh, Schneider, Julie A., Shellcross, Lenny, Smith, Amanda G, Snyder, Heather M. , Tapply, Beth, Teunissen, Charlotte, Flier, Wiesje M. van der, Vellas, Bruno, Williamson, Jeff D. , Wilcock, Donna, Carrillo, Maria C., Amouyel, Philippe , Andrieu, Sandrine , Bradshaw, Angela C. , Dumont, Magali , Grinberg, Lea T. , Iwatsubo, Takeshi , Hansson, Oskar , Jack, Clifford R. , Jicha, Gregory A. , Mahinrad, Simin , McDade, Eric , Mummery, Catherine J. , Petersen, Ronald C. , Schneider, Julie A. , Teunissen, Charlotte E. , Flier, Wiesje M. van der , Vellas, Bruno , Wallon, David , Carrillo, María C.

Mayo Clinic

Alzheimer's & Dementia | June 16, 2026 | Volume: 22 | Issue: 6 | Pages: No page available

10.1002/alz.71536 | PMID 42298289 Get It

Abstract Since 2016, the Alzheimer's Association and the Fondation Alzheimer have hosted Global Alzheimer's Leadership Series (GoALS) global think tanks, with world‐leading experts for innovative discussions to advance Alzheimer's disease (AD) research and care. The second GoALS think tank, held in June 2024 in Paris, focused on the relationship between biological changes and clinical manifestations of AD in the context of the evolving therapeutic landscape. Discussions spanned real‐world experiences of providers, patients, and their families, theoretical considerations, and health system challenges. The lived experience perspective was central to these discussions. The importance of shared decision‐making, clear and transparent communication, and the need for real‐world data to holistically support patients during their experiences were highlighted. This manuscript shares key insights from both the think tank meeting in Paris and a featured research session at the 2024 Alzheimer's Association International Conference that expanded the discussion themes for broader dissemination with the community.
International Delphi consensus on single‐port robotic radical prostatectomy: patient selection, surgical technique, and training
Soputro, Nicolas , Bjurlin, Marc, Srivastava, Abhishek , Umbreit, Eric, Eltemamy, Mohamed , Pak, Raymond, Gelikman, David G. , Hopson, Nicholas, Geskin, Albert , Mehrazin, Reza, VanDyke, Maia, Nguyen, Carvell, Ornstein, David, Billah, Mubashir , Russell, Christopher, Yuh, Bertram, Thong, Alan, Olivares, Ruben, Shetty, Sugandh, Shakuri‐Rad, Jaschar , Baccala, Angelo, Osinski, Thomas, Simone, Giuseppe, Lee, D Y , Baker, Mark, Ramadan, Mohammad, Mattei, Agostino , Jafri, Mohammad, Galfano, Antonio, Link, Richard E. , Lam, Po, Jones, Marklyn, Bassett, Jeffrey C. , Musi, Gennaro, Schwen, Zeyad , Beksaç, Alp Tuna , Eden, C, Miller, Scott, Gontero, P, Amparore, Daniele, Porpiglia, Francesco, Vourganti, Srinivas , Ahmed, Mutahar, Montorsi, Francesco, Perdona, Sisto, Izzo, Alessandro, Stifelman, Michael D., Crivellaro, Simone, Briganti, Alberto, Kaouk, Jihad, Autorino, Riccardo, Soputro, Nicolas A , Eltemamy, Mohamed , Gelikman, David G , Geskin, Albert , Palese, Michael , Link, Richard E , Rais‐Bahrami, Soroush , Bjurlin, Marc A. , Umbreit, Eric , Mehrazin, Reza , VanDyke, Maia , Yuh, Bertram, Thong, Alan Eih Chih , Olivares, Ruben , Baccala, Angelo A., Osinski, Thomas L. , Simone, Giuseppe , Crouzet, Sébastien , Ramadan, Mohammad Said , Porreca, Angelo , Jafri, Syed M., Galfano, Antonio , Amparore, Daniele , Ahmed, Mutahar, Montorsi, Francesco , Perdonà, Sisto , Izzo, Alessandro , STIFELMAN, MICHAEL D. , Crivellaro, Simone, Briganti, Alberto , Kaouk, Jihad , Autorino, Riccardo

Mayo Clinic

BJU International | June 16, 2026 | Volume: 138 | Issue: 3 | Pages: 456-463

10.1111/bju.70346 | PMID 42297464 Get It

Introduction The introduction of the purpose‐built single‐port (SP) robotic platform has allowed for the advent of regionalized minimally invasive surgical approaches for robotic radical prostatectomy (RARP), including the extraperitoneal and transvesical techniques. This study sought to develop a best practice consensus on the key principles, patient selection, surgical techniques, expected clinical outcomes, and learning curves pertaining to SP‐RARP. Methods A modified Delphi consensus was developed by a panel of experts, consisting of a 33‐item questionnaire, with each statement rated using a binary Likert scale (‘agree’ or ‘disagree’). The survey was distributed via email to all practicing SP‐RARP surgeons across the USA and Europe. Consensus was defined as ≥75% agreement on a given statement. Results A total of 53 surgeons participated in the Delphi Consensus across the two rounds. Of 33 statements, 28 (84.8%) reached agreement in the first round. The remaining consensus was achieved in the second round, involving 35 surgeons, and with one additional statement. The panel agreed that, although are no absolute contraindications to SP‐RARP, the preference towards specific SP‐RARP techniques should remain guided by the individual patients and surgical expertise. Although the SP extraperitoneal technique is recommended to pursue pelvic lymph node dissections, the panel agreed that transvesical SP‐RARP showed promise in promoting shorter hospital stay, faster recovery of urinary continence, and utility in patients with extensive prior abdominal surgery. Consensus was also reached on the need for a structured training pathway, with most recommending beginning with extraperitoneal SP‐RARP before advancing to the transvesical approach. Conclusion This Delphi consensus demonstrates broad agreement among experienced SP surgeons in the USA and Europe, forming the foundation for future research on the clinical utility and necessary training pathways for SP‐RARP. Nevertheless, empirical validation based on clinical data from large cohort studies remains important.
Aqueous Humour Outflow Assessment Using Imaging‐Based Techniques in Angle‐Based Minimally Invasive Glaucoma Surgery ( MIGS) : A Systematic Review
Ang, Bryan Chin Hou, Jin, Eric , Yeo, Selvie , Strohmaeir, Clemens A., Dada, Tanuj, Huang, Alex S. , Ang, Bryan C H , Dada, Tanuj

Mayo Clinic

Clinical & Experimental Ophthalmology | June 16, 2026 | Volume: 54 | Issue: 6 | Pages: 779-795

10.1111/ceo.70132 | PMID 42297373 Get It

ABSTRACT Background The adoption of angle‐based minimally invasive glaucoma surgery (MIGS) procedures has accelerated in recent years; however, inherent limitations remain. Imaging‐based techniques across the pre‐, intra‐ and post‐operative stages of surgery may facilitate patient selection and improve surgical outcomes. This systematic review explores the application of imaging‐based techniques to visualise aqueous humour outflow (AHO) in angle‐based MIGS. Methods A literature search was performed on PubMed, EMBASE and Cochrane Library from inception to 16 February 2025. Cohort, cross‐sectional and observational studies reporting the use of imaging‐based techniques to visualise AHO in angle‐based MIGS were included in this review. Results An initial 393 studies were identified, with 21 studies included in final analysis. Imaging techniques reported in literature included various methods to directly observe episcleral veins, haemoglobin venous imaging (HVI), fluorescein and indocyanine green (ICG) aqueous angiography, channelogram and anterior segment optical coherence tomography angiography (AS‐OCTA). Visualisation of AHO pre‐ and intra‐operatively may predict surgical outcomes, aiding in patient selection and surgical prognostication. Intra‐operative imaging may facilitate targeted placement of MIGS in areas of initially angiographically low or high areas of AHO. AHO assessment pre‐, intra‐ and post‐operatively may allow comparative analysis of surgical success and efficacy across various angle‐based MIGS. Conclusions Imaging‐based techniques visualising AHO have significant potential to improve surgical outcomes of angle‐based MIGS.
Awake Spine Surgery: A 5-Year Institutional Experience in Academic and Ambulatory Settings
Deloso, Eric , Blasingame, Maya, Saleh, Abdullah Wael, Abd-El-Barr, Muhammad M., Kent, Michael, Bullock, W. Michael , Guinn, Nicole R. , Abd‐El‐Barr, Muhammad M.

Mayo Clinic

Journal of Neurosurgical Anesthesiology | June 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ana.0000000000001126 | PMID 42290502 Get It

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis
Wilson, Matthew R. , Lewis, Katharine L. , Kirkwood, Amy A., Cwynarski, Kate , Cheah, Chan Y. , El-Galaly, Tarec C., Villa, Diego , Savage, Kerry J. , Bobillo, Sabela , Smedby, Karin E. , Puckrin, Robert , Fox, Christopher P. , Bishton, Mark, Thanarajasingam, Gita , Hapgood, Greg , Soussain, Carole , Choquet, Sylvain , Mel, Sanjay De , Preston, Gavin, Hawkes, Eliza A. , Clavert, Aline, Ku, Matthew , Narkhede, Mayur , Durot, Éric , Smith, Jeffrey , Eyre, Toby A. , Ghione, Paola , E Smedby, Karin , Harrysson, Sara , Trnĕný, Marek , Puckrin, Robert , Fox, Christopher P , Thanarajasingam, Gita , Doo, Nicole Wong , Hapgood, Greg , Soussain, Carole , Choquet, Sylvain , Dickinson, Michael , Talaulikar, Dipti , Preston, Gavin , Ahearne, Matthew , Hawkes, Eliza , Schorb, Elisabeth , Clavert, Aline , Ku, Matthew , Narkhede, Mayur S , Calimeri, Teresa , Durot, Eric , Smith, Jeffrey , Renaud, Loïc , McKay, Pamela , Eyre, Toby A , Savage, Kerry J , Cheah, Chan Yoon , Lewis, Katharine L , Kirkwood, Amy, El‐Galaly, Tarec Christoffer , Ghione, Paola , Trněný, Marek , Klánová, Magdalena , Bishton, Mark , Doo, Nicole Wong , Dickinson, Michael , Talaulikar, Dipti , Guidetti, Anna

Mayo Clinic

Journal of Clinical Oncology | June 11, 2026 | Volume: 44 | Issue: 24 | Pages: 2290-2302

10.1200/jco-26-00947 | PMID 42274647 Get It

PURPOSE In large B-cell lymphoma (LBCL), use of high-dose methotrexate (HD-MTX) to prevent CNS relapse (so-called CNS prophylaxis) remains controversial. International guidelines continue to recommend HD-MTX in patients deemed ultra high risk (UHR) because of a lack of robust data specific to these subgroups. This study was designed to examine the impact of HD-MTX specifically in UHR patients. METHODS Data from two previous retrospective analyses were combined to produce a cohort of UHR patients (≥1 of the following criteria: CNS international prognostic index score 5-6; testicular, renal/adrenal, or breast involvement; ≥3 extranodal sites), treated with or without HD-MTX. The primary outcome was CNS relapse rate (isolated or concurrent with systemic relapse) measured from diagnosis with additional landmark analysis of all responding patients with no progression event at 6 months. RESULTS Analyses were performed on 1,923 patients meeting UHR criteria. No significant difference in 3-year CNS relapse rate was observed between no HD-MTX (n = 1,051) versus HD-MTX patients (n = 872), including in multivariable analyses adjusting for baseline characteristics (3-year rate, 9.3% v 8.1%; adjusted hazard ratio [HR], 1.13 [95% CI, 0.82 to 1.57]). Analyses restricted to isolated CNS relapse also confirmed no difference (5.9% v 5.7%; adjusted HR, 1.03 [95% CI, 0.69 to 1.53]). In the landmark analysis (no HD-MTX n = 782, HD-MTX n = 773), no difference in 3-year CNS relapse was observed (6.7% v 6.6%, adjusted HR, 0.95 [95% CI, 0.62 to 1.44]). CONCLUSION To our knowledge, this is the largest international comparative data set of patients with LBCL with UHR features showing no significant reduction in CNS relapse with HD-MTX in all UHR or in any individual subgroup. Despite inherent limitations of retrospective analyses, the data strongly support previous studies in suggesting HD-MTX prophylaxis has no meaningful benefit for most patients.
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants
So, Isis , Staffaroni, Adam M. , Coleman, Kristy , Bouzigues, Arabella , Ferry‐Bolder, Eve , Cullen, Eva , Russell, Lucy L. , Foster, Phoebe H. , Farley, Sophie , Thompson, Alexander, Ber, Isabelle Le , Körtvelyessy, Péter , Schroeter, M., Uzelac, Željko , Kruger, Johanna S. W. , Langheinrich, Tobias , Ducharme, Simon , Santana, Isabel J., Tartaglia, Carmela, Mendonca, Alexandre de, Morenoizco, Fermin, Brushaber, Danielle, Considine, Ciaran , Faber, Kelley, Fagan, Anne, Fields, Julie, Foroud, Tatiana, Forsberg, Leah K. , Geschwind, Daniel, Heuer, Hilary W. , Huang, Eric, Kantarci, Kejal, Kolander, Tyler , Lago, Argentina Lario , Lavigne, Shannon B., Mester, Carly , Molden, Joie, Petrucelli, Leonard , Rademakers, Rosa , Ramos, Eilana, Rankin, Katherine P., Rascovsky, Katya, Rhoads, Kristoffer , Weintraub, Sandra, Wong, Bonnie, Boxer, Adam L. , Rosen, Howard J. , Lee, Suzee E. , Lombardi, Jolina , Staffaroni, Adam M , Coleman, Kristy K L , Bouzigues, Arabella , Ferry-Bolder, Eve , Cullen, Eva , Russell, Lucy L , Foster, Phoebe H , Farley, Sophie , Convery, Rhian , Van Swieten, John C , Jiskoot, Lize C , Seelaar, Harro , Galimberti, Daniela , Vandenberghe, Rik , Laforce, Robert , Bruffaerts, Rose , Bertoux, Maxime , Lebouvier, Thibaud , Solje, Eino , Xiong, Chengjie , di Fede, Giuseppe , Le Ber, Isabelle , Migliaccio, Raffaella Lara , Körtvélyessy, Peter , Logroscino, Giancarlo , Otto, Markus , Uzelac, Zeljko , Illán-Gala, Ignacio , Krüger, Johanna , Nacmias, Benedetta , Gerhard, Alexander , Langheinrich, Tobias , Ducharme, Simon , Masellis, Mario , Rowe, James B , Graff, Caroline , Synofzik, Matthis , Borroni, Barbara , Sánchez-Valle, Raquel , Considine, Ciaran M , Forsberg, Leah K , Gendron, Tania F , Heuer, Hilary W , Huang, Eric , Kolander, Tyler , Mester, Carly , Petrucelli, Leonard , Rademakers, Rosa , Vandebergh, Marijne , Boeve, Brad , Boxer, Adam , Rosen, Howard J , Lee, Suzee E , Rohrer, Jonathan D , Finger, Elizabeth C. , Lombardi, Jolina , Swieten, John C. van , Jiskoot, Lize C. , Seelaar, Harro , Galimberti, Daniela , Vandenberghe, Rik , Laforce, Robert , Lebouvier, Thibaud , Xiong, Chengjie , Thompson, Alexander G. , Logroscino, Giancarlo , Otto, Markus , Illán‐Gala, Ignacio , Nacmias, Benedetta , Tartaglia, Carmela M., de Mendonça, Alexandre , Rowe, James B. , Graff, Caroline , Moreno, Fermín , Synofzik, Matthis , Borroni, Barbara , Sánchez‐Valle, Raquel , Brushaber, Danielle , Fagan, Anne M. , Gendron, Tania F. , Geschwind, Daniel, Kantarci, Kejal , Ramos, Eliana Marisa , Rankin, Katherine P. , Vandebergh, Marijne , Weıntraub, Sandra , Boeve, Bradley F. , Rohrer, Jonathan D.

Mayo Clinic

No container title available | June 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.08.26355165 | PMID 42326777 Get It

ABSTRACT Background and Objectives Converging evidence hints at neurodevelopmental effects in genetic frontotemporal degeneration (FTD). In cross-sectional studies, for some genes, young adult FTD variant carriers show differences in brain volumes and cognition compared to familial non-carriers. However, longitudinal trajectories may more sensitively capture FTD-related neurodevelopmental vs. neurodegenerative changes than cross-sectional approaches. This study examined longitudinal trajectories of brain volumes, executive function, and plasma biomarkers in young adult carriers compared to familial non-carriers, as measures of neurodevelopmental and neurodegenerative outcomes of FTD-causing variants. Methods This longitudinal cohort study comprised participants, aged 18-30 years, from the FTD Prevention Initiative across Europe, Canada, and the USA. Genetic groups included C9orf72 (47%), MAPT (30%), and GRN (23%). Linear mixed-effects models were computed to assess longitudinal outcomes across age between groups, controlling for sex, scanner (for brain volumes), and education (for executive function); random effects accounted for between-subject variability nested within family membership. Results Variant carriers ( n =147) and familial non-carriers ( n =113) did not differ in age (mean±SD, 25.9±3.2 years), sex (53% female), or number of visits (2.1±1.7). Young adult C9orf72 repeat expansion carriers exhibited smaller thalamic volumes than non-carriers at the reference age of 26 years ( b =-982.8mm 3 , SE=317.0, p= 0.0046, f 2 =0.32), with relatively stable trajectories across ages 18-30 (i.e., no change over time). Trajectories of rostral anterior cingulate volumes differed in C9orf72 carriers and non-carriers across age, where carriers showed relatively stable trajectories and non-carriers showed age-appropriate declines ( b =64.4mm 3 , SE=29.9, p= 0.035, f 2 =0.07). For MAPT and GRN , there were little to no differences in total brain, cortical, or subcortical volumes between groups and over time. No longitudinal differences were observed between carriers and non-carriers in executive function, or plasma NfL or GFAP for any genetic group. Discussion C9orf72 repeat expansions were linked to smaller average thalamic volumes and stable trajectories between ages 18 to 30, supporting potential neurodevelopmental origins. The modest evidence supporting an absence of difference in neurodegenerative biomarkers and executive function suggests minimal early neurodegeneration and functional preservation in young adulthood.
Downbeat Nystagmus in Association With the Dorsal Midbrain Syndrome (P11-17.009)
Saab, Lea, Eggenberger, Eric, Cho, Catherine, Friedrich, Maximilian, Galetta, Steven, Rucker, Janet, Cho, Catherine, Galetta, Steven , Rucker, Janet C.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215769 Get It

Retinal Pigment Epithelial Changes in MELAS (P10-17.005)
Kotay, Manisha , Eggenberger, Eric, Mashayekhi, Arman

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217362 Get It